PreludeDx
Developer of decision-making, actionable tools designed to detect early-stage breast cancer. The company's platform combines proteomic analysis with artificial intelligence to assess recurrence risk a...
Valuation
$0
Share Price
N/A
Total Raised
$63M
Last Round
N/A